Avantor Inc.

Company Snapshot

Founded: 1904
Entity Type: Public
Employees: 13,500
Region: U.S.
Revenue: $6,783.6 Millions
Revenue Year: 2024
Headquarter: Pennsylvania, U.S.
Key Geographics: Americas, Europe, AMEA, U.S.
Corporate Address: Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road Radnor, Pennsylvania 19087 U.S. Tel. +1-610-386-1700 www.avantorsciences.com

Company Overview

Founded in 1904, Avantor provides mission-critical products and services to government, biopharma, education, healthcare, and advanced technologies. With over 300,000 customer locations and access to over 180 countries' research laboratories and scientists, Avantor aims to set science in motion to create a better world. The company offers a comprehensive solution for scientists, including materials, consumables, equipment, instrumentation, services, and specialty procurement. The company focuses on customer-centric innovation, identifying and developing content for customers' production platforms. The company's broad portfolio, integrated business model, and global supply chain support customers' journeys.

Financial Highlights (FY 2024)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
Operating Income: ***

This information is available for BCC Research members only.

Avantor Inc. In Reports

Bioprocess Filtration: Global Markets

Our detailed report on the Bioprocess Filtration Markets report, presenting revenue estimates (in USD Millions) for the base year 2024 and market forecasts for the 2025 to 2030 period.

High-Purity Solvents: Global Markets

Our Research report provides an overview of the High-Purity Solvents Markets provides a comprehensive analysis of the high-purity solvents market, including forecasts for its growth from 2025 to 2030.

Chromatography in Pharmaceuticals and Biotechnology: Global Markets

BCC Research Market Analyst says global market for chromatography in pharmaceuticals and biotechnology is estimated to grow from $13.3 billion in 2025 to reach $19.8 billion by the end of 2030.

Company's Business Segments

  • Laboratory Solutions : This segment includes Procurement and Material Management Services, General Lab Services, Technical Lab Services, Production Services, Downstream Optimization Services, Business Process Consulting.
  • Bioscience Production : This segment includes Monoclonal Antibodies, Recombinant Proteins, Gene Therapies, Vaccines, Cell Therapies, mRNA Vaccines and Therapies, Fluid Handling Technologies, Buffer Management, Small Molecule Products, The Process of Drug Development.

Applications/End User Industries

  • Healthcare
  • Controlled Environment
  • Life Sciences
  • Lab Design and Furniture
  • Biopharma Production
  • Chromatography
  • Quality Control & Testing
  • Advanced Technologies & Applied Materials
AI Sentiment